<DOC>
	<DOCNO>NCT03032003</DOCNO>
	<brief_summary>To investigate oral administration 240mg PAC cranberry reduce number episode acute bacterial cystitis improve general QoL woman recurrent bacterial cystitis . In addition , effect vagina rectal flora study adverse effect profile drug report . Women â‰¥3 symptomatic episode low UTIs previous year recruit outpatient population present family physician specialist symptomatic recurrent UTI . Informed consent obtain patient divide group accord age . Urinary culture , vaginal rectal swab take patient . Antibiotic treatment prescribed ( use drug choice accord urine culture treat physician choice ) . Subsequently , randomize receive combine antibiotic treatment one capsule Cysticlean 240mg PAC two time per day antibiotic treatment placebo . At 14th day post treatment negative urinary culture patient continue receive per o , daily , one capsule Cysticlean 240mg bed time 12 month placebo respectively . Study visit occur 3rd , 6th , 9th 12th month treatment phase . A urine collection , vaginal swab rectal swab take study entry month 3 , 6 , 9 12 visit . Participants ask medication usage , side effect may experience study visit . If participant develop UTI time study , ask visit study site within 24 hour .</brief_summary>
	<brief_title>Prophylactic Use Cranberries Recurrent Bacterial Cystitis Women</brief_title>
	<detailed_description />
	<mesh_term>Urinary Tract Infections</mesh_term>
	<mesh_term>Cystitis</mesh_term>
	<criteria>Negative urine culture At least 3 UTI 's within 12 month prior study entry Anatomic abnormality urinary tract Use investigational drug within 30 day prior study entry Current use warfarin Allergy intolerance cranberry product &gt; 50 ml residual urine ( measure US ) Use indwell catheter uncontrolled diabetes creatinine &gt; 250 mmol/l , Symptomatic vaginitis Pregnant breastfeeding</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>